Milbemycin A4 oxime [CAS 93074-04-5]

Milbemycin A4 oxime (5-Ketomilbemycin A4 oxime; 5-Oxomilbemycin A4 5-oxime) is a derivative of Milbemycin A4 and a component of Milbemycin oxime (HY-B0778), both of which have insecticidal and nematicidal activities. Milbemycin A4 oxime (0.05 mg/kg) reduces the number of microfilariae in naturally infected dogs with D. immitis and inhibits the growth of clinical isolates of Candida glabrata (MIC80=16-32 μg/mL). Milbemycin A4 oxime (2.5 μg/mL) blocks the efflux of Fluconazole (HY-B0101) from clinical isolates of Candida glabrata. Milbemycin A4 oxime enhances doxorubicin-induced cell growth inhibition and increases the intracellular accumulation of doxorubicin and P-glycoprotein substrate Rhodamine 123 (HY-D0816) in doxorubicin-resistant but not sensitive MCF-7 breast cancer cells in a concentration-dependent manner.

[93074-04-5]

C32H45NO7

555.7

O[C@@]([C@@](C(O[C@]1([H])C[C@](O[C@@H]2CC)(CC[C@@H]2C)O[C@@]3([H])C1)=O)([H])C=C/4C)(/C5=C/C=C/[C@@H](C/C(C)=C/C3)C)[C@@](OC5)([H])C4=N\O

Parasite

Room temperature